Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Phosphatidylinositide-3 kinase: a newer molecular target in metabolic and hormonal pathway of polycystic ovary syndrome.

Shah KN, Patel SS.

Exp Clin Endocrinol Diabetes. 2014 May;122(5):261-7. doi: 10.1055/s-0034-1372578. Review.

PMID:
24710644
2.

Selective insulin resistance in the polycystic ovary syndrome.

Book CB, Dunaif A.

J Clin Endocrinol Metab. 1999 Sep;84(9):3110-6.

PMID:
10487672
3.

Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome.

Mukherjee S, Maitra A.

Indian J Med Res. 2010 Jun;131:743-60. Review.

4.

Persistence of hyperinsulinemia in polycystic ovary syndrome after ovarian suppression by gonadotropin-releasing hormone agonist.

Dale PO, Tanbo T, Djøseland O, Jervell J, Abyholm T.

Acta Endocrinol (Copenh). 1992 Feb;126(2):132-6.

PMID:
1543018
5.

Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome.

Wu XK, Zhou SY, Liu JX, Pöllänen P, Sallinen K, Mäkinen M, Erkkola R.

Fertil Steril. 2003 Oct;80(4):954-65.

PMID:
14556818
6.

Phosphatidylinositide 3-kinase inhibition: A new potential target for the treatment of polycystic ovarian syndrome.

Shah KN, Patel SS.

Pharm Biol. 2016;54(6):975-83. doi: 10.3109/13880209.2015.1091482.

PMID:
26459667
7.

[Effect of 6-month treatment with oral antiandrogen alone and in combination with insulin sensitizers on body composition, hormonal and metabolic parameters in women with polycystic ovary syndrome (PCOS) in order to determine therapeutic strategy].

Orbetsova M, Kamenov Z, Kolarov G, Zakharieva S, Khristov V, Atanasova I, Shigarminova R, Milcheva B, Genchev G.

Akush Ginekol (Sofiia). 2006;45(7):16-28. Bulgarian.

PMID:
17489164
8.

Potential role and therapeutic interests of myo-inositol in metabolic diseases.

Croze ML, Soulage CO.

Biochimie. 2013 Oct;95(10):1811-27. doi: 10.1016/j.biochi.2013.05.011. Review.

PMID:
23764390
9.

Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.

Lam UD, Lerchbaum E, Schweighofer N, Trummer O, Eberhard K, Genser B, Pieber TR, Obermayer-Pietsch B.

Gene. 2014 Mar 10;537(2):245-52. doi: 10.1016/j.gene.2013.12.055.

PMID:
24388959
10.

Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited.

Kurzrock R, Cohen PR.

Med Hypotheses. 2007;68(3):480-3.

PMID:
17134841
11.

Insulin sensitizers in polycystic ovary syndrome.

Pasquali R, Gambineri A.

Front Horm Res. 2013;40:83-102. doi: 10.1159/000341837. Review.

PMID:
24002407
12.

Insulin resistance in polycystic ovary syndrome.

Prelevic GM.

Curr Opin Obstet Gynecol. 1997 Jun;9(3):193-201. Review.

PMID:
9263704
13.

Molecular mechanisms of insulin resistance in polycystic ovary syndrome.

Diamanti-Kandarakis E, Papavassiliou AG.

Trends Mol Med. 2006 Jul;12(7):324-32. Review.

PMID:
16769248
14.

Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study.

Sahin I, Serter R, Karakurt F, Demirbas B, Culha C, Taskapan C, Kosar F, Aral Y.

Gynecol Endocrinol. 2004 Sep;19(3):115-24.

PMID:
15697072
15.

Adolescent androgen abnormalities.

Stafford DE, Gordon CM.

Curr Opin Obstet Gynecol. 2002 Oct;14(5):445-51. Review.

PMID:
12401970
16.

Understanding the underlying metabolic abnormalities of polycystic ovary syndrome and their implications.

Taylor AE.

Am J Obstet Gynecol. 1998 Dec;179(6 Pt 2):S94-S100. Review.

PMID:
9855615
17.
18.

Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome.

Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G.

N Engl J Med. 1999 Apr 29;340(17):1314-20.

19.

Use of insulin-sensitizing agents in patients with polycystic ovary syndrome.

Bloomgarden ZT, Futterweit W, Poretsky L.

Endocr Pract. 2001 Jul-Aug;7(4):279-86. Review.

PMID:
11497481
20.

Insulin resistance and the long-term consequences of polycystic ovary syndrome.

Bhathena RK.

J Obstet Gynaecol. 2011;31(2):105-10. doi: 10.3109/01443615.2010.539722. Review.

PMID:
21281021
Items per page

Supplemental Content

Support Center